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Abstract: There exists an intermediate group of individuals whose glucose levels do not meet the
criteria for diabetes yet are higher than those considered normal (prediabetes mellitus (preDM)).
Those people have a higher risk of developing diabetes in the future. Gynura bicolor (GB) is a red-
purple-colored vegetable, which is common in Taiwan. GB has shown antioxidant, anti-inflammatory
and anti-hyperglycemic effects in previous studies. The aim of this study was to assess the effects
of serving two serving sizes of GB every day on the glycemic control and antioxidant ability of
preDM subjects. According to the age and anthropometry data of the participates, we assigned
them into a control or GB group for the 8-week intervention and 4-week washout period. Data of
anthropometry and biochemical analysis were collected at 0, 8 and 12 weeks. Oral glucose tolerance
tests were performed, and we collected dietary records on the baseline and Week 8. Both groups
received nutrition education and a diet plan individually. After intervention, the fasting glucose
and malondialdehyde (MDA) values were significantly decreased in the GB group. HOMA-IR and
QUICKI values were improved, and antioxidant activity was increased in the GB group. GB could
improve glycemic control and decrease oxidative stress because of its large amounts of polyphenols.
Keywords: Gynura bicolor; prediabetes; phytochemical; blood glucose; oxidative stress
1. Introduction
According to The American Diabetes Association (ADA), people whose fasting plasma
glucose (FPG) level is 100 to 125 mg/dL were defined as impaired fasting glucose (IFG), or
whose 2 h value in the oral glucose tolerance test (OGTT) is 140 to 199 mg/dL were defined
as impaired glucose tolerance (IGT), or individuals with glycated hemoglobin (HbA1c)
of 5.7–6.4%. People who meet one of three diagnosis criteria were called “prediabetes
(preDM)” [1]. Individuals with both IFG and IGT have more severe dysglycemic condition
and are especially at high-risk for type 2 diabetes [2]. According to the International
Diabetes Federation (IDF), in 2019, there were 463 million people with preDM, and this
number is expected to reach 700 million by 2045 [3]. In total, 5–10% of individuals with
preDM develop diabetes annually, with up to 70% eventually developing diabetes. Several
trials have reported on the risk of diabetes development in preDM individuals after lifestyle
and drug-based interventions. PreDM can convert back to normoglycaemia [4,5].
Under hyperglycemia or IR condition, oxidative stress will be increased and endothe-
lial dysfunction will occur [6]. The endothelium is a key regulator of vascular function [7],
when dysfunction will cause inflammation, vasoconstriction, thrombosis and platelet ac-
tivation, which are linked with atherosclerosis [8]. Evidence from prospective studies
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suggest that cardiovascular disease (CVD) may be associated with preDM [9]. Lifestyle
intervention includes diet modification, weight reduction or moderate physical activity.
Some studies reported that intensive lifestyle interventions such as achieving and main-
taining ideal body weight may prevent the progression to type 2 diabetes in IGT or IFG
subjects [10]. In the Da Qing trial in China, 577 individuals with IGT were randomized to
dietary counseling, increased exercise, diet plus exercise or control (general recommen-
dations). The cumulative 6-year incidence of diabetes was significantly lower in the diet
group (43.8%), the exercise group (41.1%) and diet plus exercise group (46.0%) than the
control group (67.7%). In a proportional hazards analysis adjusted for differences in base-
line BMI and fasting glucose, the diet, exercise, and diet-plus-exercise interventions were
associated with 31% (p < 0.03), 46% (p < 0.0005), and 42% (p < 0.005) reductions in risk of
developing diabetes, respectively [11]. In a meta-analysis, it was reported that consuming
large amounts of vegetables and fruits may reduce the risk of diabetes and associate to
inflammation and oxidative stress [12]. Giugliano reported that diets containing vegetables
and fruits, n-3 fatty acids and fiber attenuate the inflammation [13]. Phytochemicals such
as vitamin C, vitamin E, carotenoids, phytosterols, anthocyanins and alkaloids showed
anti-inflammation and antioxidant effects [14].
Anthocyanins belong to the widespread class of phenolic compounds collectively
named flavonoids. Mechanic studies support the beneficial effects of flavonoids, including
anthocyanins, on the biomarkers of CVD risk such as NO, inflammation and endothelial
dysfunction. The role of anthocyanins in CVD prevention is strongly related to against
oxidative damage [15]. Red-purple vegetables are rich in anthocyanins, the common
vegetables in Taiwan such as purple-leaved sweet potato, Gynura bicolor (GB) and purple-
leaved celosia. GB is widely distributed in Asia and common cuisine in Taiwan. The
leaves of GB distinctively show a reddish purple color on the abxial side and a green
color on the adaxial side. Gynura is used as traditional Chinese medicine for treatment
of inflammation, fever, hypertension and diabetes [16,17]. GB has been shown to have
antioxidant, anti-inflammatory and anti-hyperglycemic effects [18–20]. However, limited
clinical human studies have examined the effects on glycemic control and antioxidant
ability in preDM subjects.
The aim of this study was to assess the effects of serving two exchanges of GB per day
on glycemic control and antioxidant ability on preDM subjects.
2. Materials and Methods
2.1. GB Extract Preparation
Fresh GB was obtained from Taiwan Seed Improvement and Propagation Station,
COA, Taiwan. Leaves of GB were removed, washed, dried and ground to fine powder.
The extract was produced from 100 mg of the lyophilized vegetable powder with a 10-fold
volume of 70% methanol (0.1% of HCl) in the shaker for 30 min at room temperature,
then centrifuged at 1400× g for 10 min at 4 ◦C, adjusted the volume of supernant and
repeated extraction for 3 times. The collected extracts were kept at −20 ◦C until used for
total polyphenol and total anthocyanin analysis.
2.2. Total Polyphenol and Total Anthocyanin Analysis of GB Extracts
Total polyphenol contents were determined by the colorimetric method using Folin–
Ciocalteau reagent [21]. Briefly, the extracts, blank or standard (galic acid), were added to
2 mL of 2% Na2CO3. After 2 min, 100 µL of 50% Folin–Ciocalteau reagent was added. The
mixture was left at room temperature in the absence of light for 30 min. The absorbance of
the colored product was measured at 750 nm. The standard curve of gallic acid was used
for calculating the polyphenol contents.
Total anthocyanins were determined by using the pH differential method [22]. Before
analysis, two dilutions of the sample were prepared, one for pH 1.0 using potassium
hydroxide buffer (0.025 M, KOH) and the other for pH 4.5 using sodium acetate buffer
(0.4 M, 54.4 g CH3COONa). Samples were diluted 100 times and waited 15 min. The ab-
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sorbance was measured at 520 and 700 nm. The concentration (mg/L) of each anthocyanin





where A is the absorbance =(A520nm −A700nm)pH1.0 − (A520nm −A700nm)pH4.5, MW is the
molecular weight (g/mol) = 449.2 g/mol for cyanidin-3-glucoside, DF is the dilution
factor = 100, and ε is the extinction coefficient = 26,900, where L (path length in cm) was 1.
2.3. Subjects
Subjects were recruited from the neighborhood near by Taipei Medical University.
Inclusion criteria include whose blood glucose data meet the preDM diagnosis: FPG
100–125 mg/dL or 2 h values in the OGTT 140–190 mg/dL or HbA1c 5.7–6.4% and
20–70 years old. Exclusion criteria were individuals with a history of diabetes or use
hypoglycemic agents/insulin in past 3 months, hepatic or renal disease, history of cardio-
vascular disease or cancer, pregnancy, breast feeding, or intending to become pregnant
during the study period, thyroid or pituitary disease, gastrointestinal disease, hematologi-
cal disorders or neurological disease, drinking alcohol or smoker. Written informed consent
was obtained from all subjects, and the study was approved by the Joint Institutional
Review Board at Taipei Medical University in Taiwan (JIRB number: 201307030).
2.4. Study Design
The 12-week study consisted of an 8-week intervention period (Week 0 to Week 8)
and a 4-week washout period (Week 8 to Week 12). Subjects were assigned to the control
group (prohibit eating red-purple food) or GB group (diet including 2 serving sizes of
GB, equivalent to 200 g of edible portion (E.P)). The experimenter weighed GB, and asked
the participants to take it home every week and cook it it by themselves. Both groups
received dietary counseling based on the guideline of the Taiwanese Association of Diabetes
Educators. Subjects were asked to do a 3-day dietary record (2 weekdays and 1 weekend)
at Week 0 and 8, and the compliance was checked by dietary record. Every 4 weeks
of the intervention period (Week 0, 4 and 8) and 4 weeks washout period (Week 12),
anthropometric data and blood pressure were measured. Anthropometric data included
height, weight, body composition, body mass index (BMI), waist and hip circumference
and waist to hip ratio. Body composition was measured by Inbody 3.0 (Biospace, Seoul,
Korea) according to the principle of biochemical impedance analysis (BIA). At Week 0 and
Week 8, blood samples were collected after they had fasted overnight.
2.5. Blood Sample Analysis
Plasma collected by centrifugation at 1500× g for 10 min at 4 ◦C was stored at −80 ◦C
until further analysis. Fasting glucose, fasting insulin and glycated hemoglobin (HbA1c),
total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipopro-
tein cholesterol (LDL-C), aspartate transaminase (AST) and alanine transaminase (ALT)
levels were analyzed at the laboratory of Taipei Medical University Hospital. Homeostatic
model assessment-insulin resistance (HOMA-IR) was calculated according to the formula
insulin (µU/mL) × glucose (mmol/L)/22.5, and the quantitative insulin sensitivity check
index (QUICKI) was calculated according to the formula 1/[log (fasting insulin) + log (fast-
ing glucose)]. Total polyphenol levels in plasma were measured by the method described
by Serafini et al. [23] using Folin–Ciocalteau reagent. Absorption at 750 nm was measured
spectrophotometrically. The other blood measurements included the ferric reducing ability
of plasma (FRAP), vitamin C and malondialdehyde (MDA), which involved standardized
methods. Glutahione peroxidase (GSH-Px) and IL-6 were measured using Cayman stan-
dard glutathione assay kit and R&D human IL-6 high sensitivity ELISA kit, respectively.
The total polyphenol content was expressed as gallic acid equivalent (GAE).
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2.6. Dietary Nutrient Intake Analysis
Daily nutrient intake was calculated as the mean daily intake from a 3-day dietary
record using the nutrient analysis software (E-kitchen, Taichung, Taiwan). Nutrient as-
sessment included total caloric intake, dietary macronutrient intake (protein, fat and
carbohydrate), dietary fiber, vitamin C and vitamin E.
2.7. Statistical Analysis
All data were expressed as the mean ± SEM. The data were analyzed using one-way
ANOVA followed by Duncan’s multiple range test, Mann–Whitney U test and paired t-test.
A value of p < 0.05 was used to indicate statistical significance.
3. Results
3.1. Total Polyphenols and Total Anthocyanins of GB
The total polyphenol of GB extract was 25.54 ± 1.77 mg GAE/g DW. The total antho-
cyanin of GB extract was 1.53 ± 0.15 mg CGE/g DW.
3.2. Baseline Characteristics and Dietary Intake of Subjects
Nine subjects (two male and seven female) assigned to the control group and nine
subjects (two male and seven female) assigned to the GB group completed the whole study
period. General baseline characteristics were shown in Table 1. There were no differences
in age or height. Although the dietary fiber intake of both groups did not show significant
differences at baseline, the intake in the GB group was significantly increased (36%) after
intervention (Table 2).
Table 1. Baseline subject characteristics.
Control GB
Sex
Male (%) 22.2 22.2
Female (%) 77.8 77.8
Age 57.6 ± 2.2 61.8 ± 2.6
Height (cm) 159.9 ± 2.8 157.9 ± 1.5
Body weight (kg) 62.6 ± 3.0 64.0 ± 3.1
BMI (kg/m2) 24.4 ± 0.6 26.0 ± 1.4
Body fat (%) 31.8 ± 1.5 32.4 ± 2.5
Fasting plasma glucose (mg/dL) 111.2 ± 6.4 125. 0 ± 3.8
Fasting insulin (mU/L) 10.6 ± 0.9 12.9 ± 1.3
HbA1c (%) 5.79 ± 0.12 6.41 ± 0.17 §
Values are mean ± SEM (n = 9), § p < 0.05 between groups by Student’s t-test, GB, Gynura bicolor; BMI, Body mass
index; HbA1c, Glycated hemoglobin.
Table 2. Dietary intake during study period.
Control GB
Week 0 Week 8 Week 0 Week 8
Energy (kcal) 1370.3 ± 144.5 1382.3 ± 88.3 1440.2 ± 143.7 1391.6 ± 123.7
Protein (%) 15.3 ± 1.0 16.2 ± 1.2 15.6 ± 1.0 17.2 ± 1.1
Fat (%) 28.9 ± 3.2 29.9 ± 1.8 28.7 ± 3.1 28.0 ± 1.7
Carbohydrate (%) 60.0 ± 3.6 54.1 ± 2.3 56.0 ± 3.3 55.7 ± 1.7
Dietary fiber (g) 14.0 ± 1.6 13.0 ± 1.2 15.0 ± 2.3 20.4 ± 2.0 §
Vitamin C (mg) 114.38 ± 40.89 104.52 ± 23.17 120.44 ± 34.40 164.72 ± 44.74
Vitamin E (α-TE) 3.38 ± 0.52 3.46 ± 0.51 3.66 ± 0.52 3.74 ± 0.66
Values are mean ± SEM (n = 9), § p < 0.05 between groups by Mann–Whitney U test, GB, Gynura bicolor; E, energy.
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3.3. Glycemic-Control-Related Markers
Glycemic-control-related markers were shown in Table 3. At baseline, there was
no difference in FPG, fasting insulin, HOMA-IR and QUICKI between groups. After an
8-week intervention, FPG and HOMA-IR were significantly decreased in the GB group
when compared with baseline. In addition, the results remain maintain after the 4-week
washout period (Week 12). The changes of fasting insulin, HOMA-IR and QUICKI in the
GB group were significant when compared with the control group (∆0–8 week).
Table 3. Effects of Gynura bicolor on glycemic control profile.
Control GB
Fasting plasma glucose (mg/dL)
Week 0 111.22 ± 6.43 125.00 ± 3.83 §
Week 8 100.11 ± 2.30 108.22 ± 2.90 §*
Week 12 101.78 ± 3.60 106.00 ± 3.51 *
40–8 week −11.11 ± 6.04 −16.78 ± 2.72
40−12 week −9.1 ± 18.8 −19.8 ± 9.3 §
48–12 week 2.1 ± 9.6 −1.4 ± 8.1
Fasting insulin (mU/L)
Week 0 10.60 ± 0.91 12.87 ± 1.32
Week 8 12.10 ± 1.61 9.89 ± 0.93
Week 12 8.99 ± 0.87 9.00 ± 1.03 *
40–8 week 1.50 ± 1.30 −2.98 ± 1.37 §
40–12 week −1.30 ± 2.7 −4.20 ± 4.8
48–12 week −2.30 ± 3.4 −1.20 ± 3.8
HbA1C (%)
Week 0 5.79 ± 0.12 6.41 ± 0.17 §
Week 8 5.76 ± 0.11 6.30 ± 0.13 §
Week 12 5.69 ± 0.11 6.14 ± 0.14 §
40–8 week −0.03 ± 0.05 −0.11 ± 0.08
40–12 week −0.10 ± 0.11 −0.26 ± 0.28
48–12 week −0.07 ± 0.10 −0.13 ± 0.18
HOMA-IR
Week 0 2.97 ± 0.39 3.95 ± 0.40
Week 8 3.02 ± 0.44 2.63 ± 0.25 *
Week 12 2.30 ± 0.27 2.34 ± 0.26 *
40–8 week 0.05 ± 0.31 −1.32 ± 0.42 §
40–12 week −0.52 ± 0.85 −1.52 ± 1.52
48–12 week −1.00 ± 1.59 −0.36 ± 0.96
QUICKI
Week 0 0.33 ± 0.01 0.31 ± 0.00
Week 8 0.33 ± 0.01 0.33 ± 0.00
Week 12 0.34 ± 0.01 0.34 ± 0.00
40–8 week −0.00 ± 0.01 0.02 ± 0.01 §
40–12 week −0.02 ± 0.11 −0.01 ± 0.11
48–12 week −0.02 ± 0.11 0.00 ± 0.11
Values are mean ± SEM (n = 9), § p < 0.05 between groups by Mann–Whitney U test; * p < 0.05 compared
with Week 0 by Mann–Whitney U test, HOMA-IR, homeostasis model assessment-insulin resistance; QUICKI,
quantitative insulin sensitivity check index.
3.4. Anthropometric Measures, Blood Pressure, Lipid Profile and Liver Function
Anthropometric measures included weight, BMI, body fat, fat-free mass, waist cir-
cumference, hip circumference and waist:hip ratio. There were no differences at baseline,
Week 4, Week 8 and Week 12 between groups or within groups (Table 4). Blood pressure,
TC, HDL-C, LDL-C, AST, and ALT levels did not differ between groups or within groups
at baseline, Week 4, Week 8 and Week 12 (Tables 5 and 6).
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Table 4. Effects of Gynura bicolor on anthropometric and body composition measures.
Control GB
Body weight (kg)
Week 0 62.56 ± 3.10 64.03 ± 3.10
Week 4 62.38 ± 2.67 64.00 ± 2.94
Week 8 62.70 ± 2.84 63.66 ± 3.11
Week 12 59.51 ± 1.92 63.31 ± 3.11
BMI (kg/m2)
Week 0 24.36 ± 0.62 25.96 ± 1.35
Week 4 24.32 ± 0.41 25.94 ± 1.25
Week 8 24.41 ± 0.42 25.54 ± 1.17
Week 12 24.00 ± 0.61 25.64 ± 1.24
Body fat (%)
Week 0 31.83 ± 1.46 32.41 ± 2.47
Week 4 30.84 ± 1.34 32.47 ± 2.46
Week 8 30.33 ± 1.22 31.38 ± 2.34
Week 12 30.88 ± 1.62 31.19 ± 2.34
Fat-free mass (kg)
Week 0 42.82 ± 2.75 42.98 ± 1.81
Week 4 43.29 ± 2.51 42.98 ± 1.89
Week 8 43.88 ± 2.66 43.40 ± 1.82
Week 12 41.11 ± 1.60 43.29 ± 1.88
Waist circumference (cm)
Week 0 85.61 ± 1.29 87.33 ± 3.00
Week 4 84.33 ± 1.39 87.56 ± 3.22
Week 8 83.00 ± 1.90 87.39 ± 2.48
Week 12 82.38 ± 1.29 84.89 ± 2.85
Hip circumference (cm)
Week 0 99.61 ± 1.50 99.56 ± 2.57
Week 4 100.11 ± 1.56 101.00 ± 2.77
Week 8 98.89 ± 1.30 98.39 ± 2.57
Week 12 95.50 ± 1.88 98.44 ± 2.19
Waist to hip ratio
Week 0 0.92 ± 0.01 0.93 ± 0.02
Week 4 0.91 ± 0.01 0.94 ± 0.02
Week 8 0.91 ± 0.01 0.93 ± 0.01
Week 12 0.91 ± 0.01 0.93 ± 0.01
Values are mean ± SEM (n = 9).
Table 5. Effects of Gynura bicolor on blood pressures.
Control GB
Systolic (mmHg)
Week 0 122.89 ± 2.80 135.33 ± 5.06
Week 4 120.89 ± 5.78 136.78 ± 6.28
Week 8 115.22 ± 6.09 133.44 ± 4.19
Week 12 110.88 ± 7.18 120.56 ± 5.23
Diastolic (mmHg)
Week 0 71.22 ± 5.17 78.22 ± 3.05
Week 4 71.78 ± 5.25 80.22 ± 3.03
Week 8 67.67 ± 4.66 77.11 ± 3.12
Week 12 63.25 ± 4.63 72.00 ± 3.54
Values are mean ± SEM (n = 9).
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Table 6. Effects of GB on blood lipid profile and liver function 1–3.
Control GB
Week 0 Week 8 Week 12 Week 0 Week 8 Week 12
Blood lipid profile
TC (mg/dL) 204.2 ± 11.8 197.0 ± 11.0 199.4 ± 11.6 197.7 ± 6.5 199.9 ± 8.9 189.6 ± 10.1
HDL-C (mg/dL) 58.7 ± 4.6 58.9 ± 5.0 61.4 ± 6.2 58.9 ± 4.2 56.2 ± 3.6 56.9 ± 3.6
LDL-C (mg/dL) 136.6 ± 11.0 128.2 ± 9.0 123.1 ± 10.4 * 131.4 ± 7.3 135.8 ± 7.3 123.7 ± 10.6
Liver function
AST (IU/L) 32.7 ± 7.3 22.8 ± 2.5 * 21.9 ± 1.3 24.8 ± 3.6 23.4 ± 2.7 21.8 ± 3.1
ALT (IU/L) 36.7 ± 11.4 23.6 ± 3.7 21.2 ± 2.4 32.1 ± 8.9 29.9 ± 6.8 26.2 ± 7.1
1 Values are mean ± SEM, 2,* p < 0.05 compared with Week 0 by Mann–Whitney U test, 3 GB, Gynura bicolor; TC, total cholesterol; HDL-C,
high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; AST, aspartate transaminase; ALT, alanine transaminase.
3.5. Oxidative-Stress-Related Markers
Oxidative-stress-related markers were shown in Figure 1. At baseline, vitamin C
(Figure 1a), total polyphenol (Figure 1b) and MDA (Figure 1e) in the GB group were
significantly different when compared with the control group. The baseline total polyphe-
nol level in the GB group was significantly lower when compared to the control group
(0.39 ± 0.01 vs. 0.43 ± 0.01). After asking clients to avoid red-purple food for 8 weeks, the
total polyphenol level in the control group was significantly decreased when comparing
Week 8 to Week 0, though neither group showed any differences at Week 8. Although
FRAP was significantly increased in both control and GB groups after 8 weeks, the delta
value from Week 0 to Week 8 in the GB group was significantly higher than the control
group (3.92 ± 0.56 vs. 1.80 ± 0.19) (Figure 1c). At Week 8, GSH-Px activity in the GB group
was significantly higher than baseline (Figure 1d). At baseline, the levels of MDA in the
GB group were significantly higher than in the control group (9.32 ± 0.62 vs. 5.88 ± 0.65).
After the intervention, the MDA levels of the GB group were significantly decreased when
comparing Week 8 to Week 0, and there were no significant differences between Week 0
and Week 8 of the control group (Figure 1e). Moreover, the differences of MDA levels
between Week 8 and Week 0 were significantly higher in the GB group when compared
to the control group (−5.23 ± 0.66 vs. −0.81 ± 0.43). There were no differences in IL-6
between groups or within groups (Figure 1f).
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(b) total polyphenols (mg/mL), (c) FRAP (mM), (d) GSH-Px (nmol/min/mL), (e) MDA (µM), and (f) IL-6 (ρg/mL). Values
are mean ± SE (n = 9). § p 0.05 et een groups by ann–Whitney U test; * p < 0.05 compared with Week 0 by Ma n–
Whitney U test; # the difference value of Week 0 and Week 8 with a significa t difference b tw en groups by Mann–Whit ey
U test (p < 0.05) FRAP, ferric reducing ability of plasma; GSH-Px, glutathione peroxidase; MDA, malondialdehy e; IL-6,
interlukin-6.
4. i
I , f ris factors for D and CVD as “syndrome X”,
the for er a f “ t . ets a e several definitions. In
Taiwan, et i fi three of the following five features: waist ircumference
>90 c in en r 80 c i , - dL in men or <50 mg/dL in women,
FP 100 mg/dL, TG ≥ 150 mg/dL and BP ≥ 130/85 mmHg. In ulin r sistance (IR)
i consider d one of the main path ph siology that cau ed Mets. IR causes abnormal
nutrient metabolism such as hepatic gluconeogenesis, lipi peroxidation and TG ynthesis.
Moreo er, vasoconstriction, oxidative stress and inflammation happe ed. Under this
conditio , it increases the risk of developing CVD [25]. In previou s udies, it s owed
that IR and β-cell dysfunction were already happening b fore devel ping to diabetes [26].
Ford et al. performed meta-analysis; it concluded that IFG and IGT are associated with
modest increases in the risk of cardiovascular dis ase. Therefore, preDM is related to
Mets [27]. In our study, all subject ’ FPG levels were over 100 mg/dL and have a large
waist circumference. We considered t e subjects in this study to be at a higher risk of
developing Mets and CVD than others.
-I was proposed as a simple and inexpensive alternative to more sophisticated
techniques by Matthew et al., and had been evaluated to be reliably used in large-scale
or epidemiological studie [28,29]. QUICKI was first performed by Katz et al. QUICKI
is a novel, simple, accurat and reproductive method for determining insulin sensitivity
in humans [30]. HOMA-IR and QUICKI can only use FPG and fasting insuli to assess
the levels of insulin resista c (IR) and insulin sensitivity. The hig r the HOMA-IR, the
higher the l vels of IR. QUICKI is the rev rse to HOMA-IR. Several studies showed the
different cutoff point of HOMA-IR and QUICKI. Ascaso et al. observed 65 subjects aged
30–60 years in Spain, showing that subjects had IR when HOMA-IR > 2.6 and QUICKI <
0.33 [31]. Keskin et al. described that the cutoff point for diagnosis of IR is >2.5 for adults
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and >3.15 for adolescents [32]. In China, a total of 2217 subjects were observed. It increases
the risks of developing Mets and diabetes when the quartile1 (Q1) of HOMA-IR > 2.8. No
matter which cutoff point they are based on, HOMA-IR and QUICKI in both groups were
abnormal before the intervention period. After an 8-week intervention of GB and a 4-week
washout period, HOMA-IR in the GB group were significantly decreased when compared
with baseline. The difference of QUICKI between baseline and the 8-week intervention
was significantly decreased when compared to the control group. Therefore, we speculated
that an intake of GB may improve the insulin resistance and elevate the insulin sensitivity.
Furthermore, the efforts of improving insulin resistance can be maintained.
Increased consumption of vegetables, whole grains, and soluble and insoluble fiber is
recommended to treat preDM and diabetes individuals. Wolfram and Ismail-Beigi collected
14 randomized clinical trials on diabetes from the past decade. They concluded that im-
proving insulin sensitivity and glucose homeostasis on a plant-based diet is more effective
than other commonly used diets, because plant-based diets contain fiber, micronutrients
(potassium, folate and magnesium) and phytochemicals such as anthocyanins, flavonoids
and chlorophyll [33–35]. The PREDIMED study (PREvencio’n con DIetaMEDiterra’nea)
conducted a 3-month clinical trial. It showed increasing dietary fiber intake with natural
food (22 g per day) on risk factors for CVD in subjects at high risk decreased FPG, TC
and increased HDL-C, which is associated with CVD risk factors [36]. Another random-
ized clinical trial suggested that a moderate amount of dietary fiber intake (7 g per day)
may be beneficial for managing the FPG but no effects on weight and BMI in Japanese
men with hyperglycemia and visceral fat obesity [37]. According to “2005–2008 Nutrition
and Health Survey in Taiwan (NAHSIT)”, the dietary fiber intake in men was 13.7 g and
14 g in women, both of which were less than 25–35 g, the recommended intake from the
Ministry of Health and Welfare (MHW). In our study, the dietary intake (13–14 g) in the
control and GB groups was no different at baseline. After an 8-week intervention of GB,
the dietary intake in the GB group was increased 6 g/day and FPG was decreased when
compared with baseline. One exchange of GB contained dietary fiber (3.1 g). Although
not reaching the recommended intake from the MHW, it did indeed raise the dietary
intake. We speculated that decreased FPG was associated with an increasing intake of
dietary fiber, which is from GB. In addition, total polyphenols and total anthocyanins of
GB extract were 25.54 ± 1.77 mg GAE/g DW and 1.53 ± 0.15 mg CGE/g DW, respectively.
A previous study showed that the main chemical components of GB are phenolic acids,
flavonoids, carotenoids and anthocyanins [38]. Using UPLC-MS/MS analysis, 53 phenolics
were identified [39]. Most polyphenols exist in the form of glycosylated derivatives in GB.
These polyphenols must undergo digestive enzymes and intestinal microbiota metabolism
to become bioactive in the human body [40]. Clinical study in obese healthy subjects did
not support the use of dietary supplementation with dried purple carrot (259.2 mg/day of
phenolic acids) to achieve weight loss, improvements in body composition, LDL-C and
blood pressure [41]. The same results were also observed in our study, because the total
polyphenol was much lower.
Several antioxidants exist in plasma, such as ascorbic acid, vitamin E, carotenoid
and polyphenols. The ability of dietary polyphenols to reduce inflammation is related
to acting as antioxidants, interfering with oxidative stress signaling, suppressing the pro-
inflammatory signaling transductions. The biological significance of phenolic compounds
is not only in direct reaction with ROS, but also in activation of cell signaling pathways [42].
FRAP is presented as a method for assessing total antioxidant power. Ferric ferrous
ion (Fe3+) reduction at low pH causes a navy blue ferrous-tripyridyltriazine (Fe2+-TPTZ)
complex form. The deeper the color, the better the antioxidant power [43]. We observed that
FRAP both in the GB group and control group were increased after an 8-week experimental
period. It meant that total antioxidant power was both enhanced. Moreover, the change
between baseline and Week 8 in the GB group was more significant than in the control group.
MDA is an intermediate product of lipid peroxidation, which usually uses thiobarbituric
acid-reactive substances (TBARS) to quantify. One study showed that smoking and alcohol
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consumption were confounding factors of MDA [44]. GSH-Px is the important enzyme
of the cell defense system. GSH-Px could breakdown peroxide to oxygen and water. The
activity of GSH-Px would decrease when peroxidant increases [45]. A previous study
observed that Aronia extract results from the influence of anthocyanins and possibly
other flavonoids on decreasing MDA and catalase and increasing GSH-Px and superoxide
dismutase activities [46]. In our study, we excluded smoker and alcohol consumption
subjects. MDA and GSH-Px in the GB group were decreased/increased in Week 8 when
compared with baseline, respectively. It showed that, after an 8-week intervention, the
oxidative stress in subjects was decreased.
Because of increasing oxidative stress, the pathophysiology of preDM and T2D were
considered as a chronic inflammation. IL-6 is an important mediator of inflammatory
response [47]. Lucas et al. observed that TNF-α and IL-6 were significantly higher in
overweight/obese young subjects with preDM (BMI > 33 kg/m2) than healthy over-
weight/obese ones [48]. It is not consistent with our study. We speculated that this is
because the study population consisted of all overweight individuals (BMI > 25 kg/m2).
The inflammation generated from adipocytes was fewer than obesity.
The bioavailability of polyphenols was influenced by the molecular weight, conjugated
form (methyl, glucuronide or sulphate) and cooking method. For most flavonoids absorbed
in the small intestine, the plasma concentration then rapidly decreases (elimination half-life
period of 1–2 h). The maintenance of a high concentration in plasma thus requires a repeated
ingestion of the polyphenols over time. Anthocyanins are quite rapidly absorbed, but their
bioavailability seems to be the lowest of all flavonoids [40]. Nielsen et al. concluded that
urinary flavonoids may be useful as a new biomarker for vegetables and fruits [49]. In the
GB group, there were no differences in total polyphenols of plasma. It could be associated
with the fact that the blood sample collection of subjects was not conducted all at the same
time. When all were finished to collect, it already passed the half-life time of polyphenols.
In the control group, total polyphenols of plasma were significantly decreased. It might be
associated with prohibiting eating red-purple food for 8 weeks. We suggested that future
studies must use urine tests to assess total polyphenol intake.
Our study was the first interventional trial using GB for preDM, by using natural
ingredients and at least eating two exchanges of vegetables every day. GB is not only
rich in fiber; it also contains higher polyphenols than other green-leafy vegetables. This
might have resulted in improvement of glycemic control and reducing oxidative stress in
preDM subjects. Although the beneficial effects of GB could be observed, some limitations
needed be addressed. (1) PreDM without medication subjects are difficult to find, because
people pay less attention to their own blood report. (2) The intervention period was 8
weeks. We did not consider that the half-life of HbA1c is about 3 months. (3) The baseline
characteristics had biases between the control group and GB group. This is because we
did not assign randomly, but based on subjects’ dietary habit. Further studies, we suggest,
should consider expanding the intervention time and the allocations of groups.
In conclusion, the subjects in our study were overweight and preDM subjects. After
intervention of two serving sizes of GB for 8 weeks, FPG and MDA were decreased, FRAP
and GSH-Px were increased in the intervention group and HOMA-IR and QUICKI were
improved. We concluded that GB could improve glycemic control and decrease oxidative
stress because of its large amounts of polyphenols. In addition, GB not only has health-care
functions, but its pigments also show potential uses as natural food colorings. Therefore,
GB extract can be used to make functional foods, such as adding to fruit mousse or yogurt.
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